Published in TB and Outbreaks Week, December 19th, 2000
"Infectious disease is humankind's oldest and most tenacious enemy," said Alan F. Holmer, PhRMA, in releasing the survey. "The industry's pipeline of weapons against infectious diseases gives cause for optimism in this ongoing battle."
The medicines currently in clinical trials or awaiting approval by the U.S. Food and Drug Administration (FDA) include: 22 medicines to attack such viruses as hepatitis, herpesviruses, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.